BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

MEDIPOST Secures FDA Agreement for Single Pivotal Phase 3 Study of CARTISTEM

MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to conduct a sing...

June 05, 2026 | News

CAS Brings Trusted Scientific Intelligence Directly Into R&D Workflows Through New Connections Framework

CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced CAS Connections, a new integration framework th...

June 05, 2026 | News

Waters Introduces Cyclic IMS P20 to Advance Structural and Spatial Omics Research

Waters Corporation has introduced the Cyclic IMS P20 Mass Spectrometer, a next generation structural and spatial omics platform designed to provide researc...

June 04, 2026 | News

Ginkgo Datapoints, Tangible Scientific and Inductive Bio Launch ADME One to Accelerate Early Drug Discovery

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projec...

June 03, 2026 | News

Leica Biosystems, Indica Labs, And Lunit Advance AI Powered Digital Pathology For PD L1 Biomarker Analysis

Building on the market-defining computational pathology partnership between Leica Biosystems and Indica Labs, this new collaboration integrates Lunit's adv...

May 29, 2026 | News

CGBIO Expands Global NOVOSIS Partnership With DePuy Synthes Into North America And Australia

DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development...

May 28, 2026 | News

SK bioscience Partners With Colombia On US$260 Million Vaccine Localization Initiative

SK bioscience collaborates with Colombia's government-led US$260 million vaccine localization initiative through technology transfer and local manufactur...

May 28, 2026 | News

Gilead Sciences Secures First FDA Approval For Hepcludex In Chronic Hepatitis Delta Virus Treatment

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod...

May 27, 2026 | News

Registrar Corp And U.S. Commercial Service Strengthen Support For Australian Exporters Entering U.S. Market

Registrar Corp, the global leader in U.S. Food and Drug Administration (FDA) regulatory compliance services, partnered with the U.S. Commercial Servic...

May 26, 2026 | Regulatory

Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...

May 26, 2026 | News

Beckman Coulter Life Sciences Commercialises Echo 650 Plus Series For Next Generation Acoustic Liquid Handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, has announced the commercial release of the Ech...

May 26, 2026 | News

Piramal Pharma Solutions Partners With Botanix Pharmaceuticals To Strengthen Sofdra Supply Chain

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development ...

May 20, 2026 | News

Ferring Pharmaceuticals Reports Real World Evidence Supporting ADSTILADRIN Re Induction In BCG Unresponsive Bladder Cancer

Re-induction with ADSTILADRIN resulted in complete responses in 31% of initial non-responders with Bacillus Calmette-Guérin (BCG)-unresponsive n...

May 19, 2026 | News

ImmunityBio Secures Exclusive US Rights To Tokyo Strain BCG To Address Chronic Bladder Cancer Treatment Shortage

Positive Phase III readout of National Cancer Institute sponsored SWOG S1602 randomized clinical trial demonstrating non-inferior efficacy of the Tokyo...

May 19, 2026 | News

Stay Connected